These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate. Minato H, Kikuta C, Masuda Y, Fujitani B, Hosoki K. Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234 [Abstract] [Full Text] [Related]
26. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia. Chandra S, White RF, Everding D, Feuerstein GZ, Coatney RW, Sarkar SK, Barone FC. Pharmacology; 1999 Jun; 58(6):292-9. PubMed ID: 10325574 [Abstract] [Full Text] [Related]
27. Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia. Korenkov AI, Pahnke J, Frei K, Warzok R, Schroeder HW, Frick R, Muljana L, Piek J, Yonekawa Y, Gaab MR. Neurosurg Rev; 2000 Sep; 23(3):145-50. PubMed ID: 11086739 [Abstract] [Full Text] [Related]
28. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. Tatlisumak T, Takano K, Meiler MR, Fisher M. Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350 [Abstract] [Full Text] [Related]
31. A comparison of the early development of ischemic brain damage in normoglycemic and hyperglycemic rats using magnetic resonance imaging. Huang NC, Wei J, Quast MJ. Exp Brain Res; 1996 Apr; 109(1):33-42. PubMed ID: 8740206 [Abstract] [Full Text] [Related]
33. Predicting final infarct size using acute and subacute multiparametric MRI measurements in patients with ischemic stroke. Lu M, Mitsias PD, Ewing JR, Soltanian-Zadeh H, Bagher-Ebadian H, Zhao Q, Oja-Tebbe N, Patel SC, Chopp M. J Magn Reson Imaging; 2005 May; 21(5):495-502. PubMed ID: 15834917 [Abstract] [Full Text] [Related]
35. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Barber PA, Hoyte L, Kirk D, Foniok T, Buchan A, Tuor U. Neurosci Lett; 2005 Nov 04; 388(1):54-9. PubMed ID: 16055267 [Abstract] [Full Text] [Related]
38. Neuroprotective effects of an immunosuppressant agent on diffusion/perfusion mismatch in transient focal ischemia. Ebisu T, Mori Y, Katsuta K, Fujikawa A, Matsuoka N, Aoki I, Umeda M, Naruse S, Tanaka C. Magn Reson Med; 2004 Jun 04; 51(6):1173-80. PubMed ID: 15170837 [Abstract] [Full Text] [Related]
39. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Belayev L, Zhao W, Pattany PM, Weaver RG, Huh PW, Lin B, Busto R, Ginsberg MD. Stroke; 1998 Dec 04; 29(12):2587-99. PubMed ID: 9836772 [Abstract] [Full Text] [Related]